---
agency: Department of Health and Human Services
applicant_types:
- Local (includes State-designated lndian Tribes, excludes institutions of higher
  education and hospitals
- Private nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Public nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- State (includes District of Columbia, public institutions of higher education and
  hospitals)
assistance_types:
- Cooperative Agreements
- Direct Loans
- Guaranteed / Insured Loans
- Sale, Exchange, or Donation of Property or Goods
authorizations:
- text: Public Health Service Act, Sections 301, 410 and 411, Public Law 78-410, as
    amended, Public Law 100-607, as amended, 42 U.S.C. 241, 42 U.S.C. 285 - 285a-1;
    Small Business Research and Development Enhancement Act of 1992, as amended, Public
    Law 102-564, as amended; 15 U.S.C. 638.
  url: null
beneficiary_types:
- Individual/Family
- Other private institution/organization
- Other public institution/organization
- Private nonprofit institution/organization
- Profit organization
- Public nonprofit institution/organization
- Quasi-public nonprofit organization
categories:
- Education - General Research and Evaluation
- Health - Health Research - General
cfda: '93.393'
fiscal_year: '2022'
grants_url: https://grants.gov/search-grants?cfda=93.393
is_subpart_f: 1
layout: program
objective: "To identify cancer risks and risk reduction strategies, to identify factors\
  \ that cause cancer in humans, and to discover and develop mechanisms for cancer\
  \ prevention and preventive interventions in humans. Research programs include:\
  \ (1) chemical, physical and molecular carcinogenesis; (2) screening, early detection\
  \ and risk assessment, including biomarker discovery, development and validation;\
  \ (3) epidemiology; (4) nutrition and bioactive food components; (5) immunology\
  \ and vaccines; (6) field studies and statistics; (7) cancer chemoprevention and\
  \ interception; (8) pre-clinical and clinical agent development; (9) organ site\
  \ studies and clinical trials; (10) health-related quality of life and patient-centered\
  \ outcomes; and (11) supportive care and management of symptoms and toxicities.\
  \ Small Business Innovation Research (SBIR) program: To expand and improve the SBIR\
  \ program; to stimulate technical innovation; to increase private sector commercialization\
  \ of innovations derived from Federal research and development funding; to increase\
  \ small business participation in Federal research and development; and to foster\
  \ and encourage participation in innovation and entrepreneurship by women and socially/economically\
  \ disadvantaged persons. \n Small Business Technology Transfer (STTR) program: To\
  \ stimulate and foster scientific and technological innovation through cooperative\
  \ research and development carried out between small business concerns and research\
  \ institutions; to foster technology transfer through cooperative research and development\
  \ between small business concerns and research institutions; to increase private\
  \ sector commercialization of innovations derived from Federal research and development\
  \ funding, and foster participation in innovation and entrepreneurship by women\
  \ and socially/economically disadvantaged persons."
obligations: '[{"x":"2022","sam_estimate":0.0,"sam_actual":674233829.0,"usa_spending_actual":721893273.09},{"x":"2023","sam_estimate":743548546.0,"sam_actual":0.0,"usa_spending_actual":742355090.15},{"x":"2024","sam_estimate":780592352.0,"sam_actual":0.0,"usa_spending_actual":763373383.82}]'
outlays: '[{"x":"2022","outlay":380367518.77,"obligation":486193704.37},{"x":"2023","outlay":154646853.34,"obligation":299761136.2},{"x":"2024","outlay":16727213.63,"obligation":176657071.4}]'
permalink: /program/93.393.html
popular_name: Cancer Cause and Prevention Research
program_type: assistance_listing
results:
- description: "FY 2016 RPG est. 645 total awards Competing FY2016 RPG actual 342\
    \ awards which were 13.3% of applications received.\r\nCompeting FY2016 SBIR/STTR\
    \ actual 13 awards which were 11.4% of applications received.\r\n"
  year: '2016'
- description: FY2017 estimated total awards to be made is 308
  year: '2017'
- description: FY2018 estimated total awards to be made is 327.
  year: '2018'
- description: FY2019 actual total awards to be made is 306.
  year: '2019'
- description: FY2020 actual total awards made was 292.
  year: '2020'
- description: FY2021 total awards to be made is 294.
  year: '2021'
- description: FY2022 actual awards made was 331.
  year: '2022'
- description: FY2023 estimated total awards to be made is 1,285.
  year: '2023'
- description: FY2024 estimated total awards to be made is 1,375.
  year: '2024'
rules_regulations: 42 CFR 52; 45 CFR 75; NIH Grants Policy Statement (10/1/16); Grants
  will be available under the authority of and administered in accordance with the
  NIH Grants Policy Statement and Federal regulations at 42 CFR 52 and 42 U.S.C. 241;
  Omnibus Solicitation of the Public Health Service for Small Business Innovation
  Research (SBIR) Grant and Cooperative Agreement Applications. Omnibus Solicitation
  of the National Institutes of Health for Small Business Technology Transfer (STTR)
  Grant Applications.
sam_url: https://sam.gov/fal/06735612e5834b828e49bc935152990e/view
sub-agency: National Institutes of Health
title: Cancer Cause and Prevention Research
usaspending_url: https://www.usaspending.gov/search/?hash=8785af02e012aadf88fd92c06a1124fd
---
